Patents by Inventor Nathan J. DUPPER

Nathan J. DUPPER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIN INHIBITORS
    Publication number: 20240408169
    Abstract: Disclosed herein are compounds of Formula (I), intermediates thereof, and methods for making the same: Also described herein are the use of such compounds and compositions for the treatment of diseases and disorders that are mediated, at least in part, by one or more cyclins, including cancer.
    Type: Application
    Filed: May 17, 2024
    Publication date: December 12, 2024
    Inventors: Andrew T. BOCKUS, Breena F. WALTON, Constantine KREATSOULAS, James B. AGGEN, Justin A. SHAPIRO, Megan DEMART, Nathan J. DUPPER, Sik Fai Siegfried LEUNG, Chinmay BHATT, Samuel METOBO, Kai YANG, Ming Hsun HO, Rajinder SINGH, Ramesh B. BAMBAL
  • CYCLIN INHIBITORS
    Publication number: 20240218021
    Abstract: Disclosed herein are compounds of Formula I and methods for making the same: Also described herein are the use of such compounds, compositions for the treatment of diseases and disorders that are mediated, at least in part, by one or more cyclins, including cancer, and intermediates useful in the preparation of these compounds.
    Type: Application
    Filed: October 20, 2023
    Publication date: July 4, 2024
    Inventors: Andrew T. Bockus, Sik Fai Siegfried Leung, David J. Earp, Pablo Santiago Garcia Dominguez, David C. Spellmeyer, Luis Hernandez, Miguel Paolo Baldomero, Catherine E. Gleason, Breena F. Walton, Rajinder Singh, James B. Aggen, Nathan J. Dupper, Justin A. Shapiro, Constantine Kreatsoulas, Ramesh B. Bambal, Chat Cheong Gabriel Fung, Mahesh Ramaseshan
  • (R) ENANATIOMER OF APLEXONE
    Publication number: 20220009891
    Abstract: R-aplexone, methods of preparing R-aplexone, or aplexone substantially free of its S-stereoisomer are disclosed. Methods of using R-aplexone or a pharmaceutically acceptable salt or solvate thereof to treat and/or prevent disease are disclosed. Methods of preparing 6-substituted tetrahydropyridine motifs with high enantiomeric excess are also disclosed.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 13, 2022
    Inventors: Oyhun KWON, Qihai XU, Nathan J. DUPPER, Jau-Nian CHEN, Adam D. LANGENBACHER